PainCeptor Pharma

company

About

PainCeptor Pharma Inc., a Montreal-based drug company focused on the treatment of chronic and acute pain.

  • 1 - 10

Details

Last Funding Type
Series A
Last Funding Money Raised
$17.20M
Industries
Medical,Pharmaceutical,Therapeutics
Founded date
Jan 1, 2004
Number Of Employee
1 - 10
Operating Status
Active

PainCeptor Pharma is a pharmaceutical company developing next generation
therapeutic drugs for the treatment of chronic and acute pain. PainCeptor's
therapeutic programs are concentrated on some of the most promising, novel,
yet scientifically validated therapeutic targets within the PNS (peripheral
nervous system). By focusing on modulating target receptors in the PNS,
PainCeptor expects to enhance the efficacy and avoid the many detrimental side
effects associated with today's pain drugs which act primarily in the CNS
(central nervous system). PainCeptor's development pipeline includes two lead
antagonist programs, targeting NGF/p75-TrkA and ASIC1a, and a third antagonist
program targeting ASIC3.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$17.20M $24.40M
PainCeptor Pharma has raised a total of $17.20M $24.40M in funding over 2 rounds. Their latest funding was raised on Mar 7, 2007 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 7, 2007 Series B $24.40M 1 Detail
Mar 22, 2004 Series A $17.20M 1 CDP Capital Technology Ventures Detail

Investors

Number of Lead Investors
Number of Investors
1
1
PainCeptor Pharma is funded by 1 investors. CDP Capital Technology Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
CDP Capital Technology Ventures Series B